|
Volumn 30, Issue 1, 2005, Pages 127-131
|
A point of view: HIV-1/AIDS is an allergy but CpG ODN treatments may inhibit virus replication and reactivate the adaptive immunity - Hypothesis and implications
|
Author keywords
Allergen like gp120; CpG ODNs; HIV 1 AIDS; IgE and IL 4 in sera; Plasmacytoid DCs; Type Iinterferons
|
Indexed keywords
ALLERGEN;
FC RECEPTOR;
GLYCOPROTEIN GP 120;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
IMMUNOGLOBULIN E;
INTERLEUKIN 4;
OLIGODEOXYNUCLEOTIDE;
SUPERANTIGEN;
TOLL LIKE RECEPTOR 9;
VACCINIA VACCINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ALLERGY;
ARTICLE;
CELLULAR IMMUNITY;
CPG ISLAND;
CYTOKINE PRODUCTION;
CYTOKINE RELEASE;
CYTOTOXIC T LYMPHOCYTE;
DENDRITIC CELL;
DRUG COST;
DRUG EFFECT;
GENE EXPRESSION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNITY;
IMMUNOGLOBULIN BLOOD LEVEL;
LANGERHANS CELL;
NONHUMAN;
PRIORITY JOURNAL;
VACCINATION;
VIRION;
VIRUS NEUTRALIZATION;
VIRUS REPLICATION;
VIRUS TRANSMISSION;
ADJUVANTS, IMMUNOLOGIC;
AIDS VACCINES;
HIV ENVELOPE PROTEIN GP120;
HIV INFECTIONS;
HIV-1;
HUMANS;
HYPERSENSITIVITY;
IMMUNITY, NATURAL;
IMMUNOGLOBULIN E;
OLIGODEOXYRIBONUCLEOTIDES;
VIRUS REPLICATION;
HUMAN IMMUNODEFICIENCY VIRUS 1;
|
EID: 14944338627
PISSN: 09208569
EISSN: None
Source Type: Journal
DOI: 10.1007/s11262-004-4590-0 Document Type: Article |
Times cited : (7)
|
References (32)
|